{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:40:19Z","timestamp":1770997219409,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.anai.2015.03.022","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T05:15:29Z","timestamp":1435295729000},"page":"4-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sublingual immunotherapy: focus on tablets"],"prefix":"10.1016","volume":"115","author":[{"given":"Giovanni","family":"Passalacqua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2015.03.022_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1067\/mai.2003.129","article-title":"Noninjection routes for immunotherapy","volume":"111","author":"Canonica","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/ACI.0b013e32831845fb","article-title":"An update on the safety of specific immunotherapy","volume":"8","author":"Windom","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(97)07055-4","article-title":"Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis","volume":"351","author":"Passalacqua","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2015.03.022_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2222.1986.tb01983.x","article-title":"Low dose sublingual therapy in patients with allergic rhinitis due to dust mite","volume":"16","author":"Scadding","year":"1986","journal-title":"Clin Allergy"},{"issue":"Suppl 52","key":"10.1016\/j.anai.2015.03.022_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1398-9995.1998.tb04987.x","article-title":"World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases","volume":"53","author":"Bousquet","year":"1998","journal-title":"Allergy"},{"issue":"Suppl 86","key":"10.1016\/j.anai.2015.03.022_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"Suppl 91","key":"10.1016\/j.anai.2015.03.022_bib7","first-page":"1","article-title":"Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009","volume":"64","author":"Canonica","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2015.03.022_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2146\/news140034","article-title":"Sublingual immunotherapy approved for grass pollen allergies","volume":"71","author":"Thompson","year":"2014","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.anai.2015.03.022_bib10","unstructured":"FDA press release. FDA approves Ragwitek for short ragweed pollen allergies. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm393820.htm. Published April 17,\u00a02014."},{"key":"10.1016\/j.anai.2015.03.022_bib11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2005.12.1358","article-title":"Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis","volume":"117","author":"Durham","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2012.08.032","article-title":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE","volume":"130","author":"Cox","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib17","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaci.2013.03.019","article-title":"Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults","volume":"131","author":"Creticos","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.anai.2013.03.013","article-title":"Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults","volume":"110","author":"Nolte","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2009.07.054","article-title":"Recommendations for appropriate sublingual immunotherapy clinical trials","volume":"124","author":"Casale","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cea.12100","article-title":"Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis","volume":"43","author":"Didier","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study","volume":"126","author":"Marogna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaci.2006.02.040","article-title":"Sublingual immunotherapy: a comprehensive review","volume":"117","author":"Cox","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2011.02761.x","article-title":"Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile","volume":"6","author":"Calder\u00f3n","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11882-014-0473-1","article-title":"Immune mechanisms of sublingual immunotherapy","volume":"14","author":"Nadeau","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.anai.2015.03.022_bib30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2217\/imt.13.117","article-title":"Under the skin or under the tongue: differences and similarities in mechanisms of sublingual and subcutaneous immunotherapy","volume":"5","author":"Ozdemir","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.anai.2015.03.022_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.1401612","article-title":"IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma","volume":"194","author":"B\u00f6hm","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2045-7022-2-2","article-title":"Mechanisms of allergen-specific immunotherapy","volume":"2","author":"Fujita","year":"2012","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1398-9995.2009.02063.x","article-title":"Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?","volume":"64","author":"Lombardi","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib34","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1399-3038.2011.01196.x","article-title":"Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: a randomized controlled study","volume":"22","author":"Pajno","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.2011.02758.x","article-title":"Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children","volume":"67","author":"Stelmach","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2014.10.013","article-title":"Grazax sublingual immunotherapy in pre-co-seasonal and continuous treatment regimens: is there a difference in clinical efficacy?","volume":"114","author":"Nakonechna","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2012.07.015","article-title":"Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy","volume":"109","author":"Stelmach","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1081-1206(10)60259-1","article-title":"Comparison of allergen immunotherapy practice patterns in the United States and Europe","volume":"103","author":"Cox","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1398-9995.2007.01608.x","article-title":"The safety of sublingual immunotherapy with one or more allergens in adults","volume":"63","author":"Lombardi","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib40","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1398-9995.2008.01742.x","article-title":"The safety of sublingual immunotherapy with one or multiple pollen allergens in children","volume":"63","author":"Agostinis","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2015.03.022_bib41","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.anai.2012.09.006","article-title":"Canonica GW Immunotherapy in polysensitized patients: new chances for the allergists?","volume":"109","author":"Ciprandi","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1939-4551-6-17","article-title":"A\u00a0WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnostics","volume":"6","author":"Canonica","year":"2013","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2015.03.022_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ACI.0000000000000084","article-title":"Allergy immunotherapy: what is the evidence for cost saving?","volume":"14","author":"Henkin","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib44","first-page":"253","article-title":"Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis","volume":"4","author":"Ronborg","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.anai.2015.03.022_bib45","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jaci.2013.09.004","article-title":"An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies","volume":"132","author":"Calderon","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.anai.2011.04.017","article-title":"Specific immunotherapy: beyond the clinical scores","volume":"107","author":"Passalacqua","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/02770903.2013.853082","article-title":"Specific immunotherapy in asthma: a comprehensive review","volume":"51","author":"Passalacqua","year":"2014","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.anai.2015.03.022_bib48","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2014.07.017","article-title":"SQ HDM SLIT-tablet (ALK) in treatment of asthma\u2014post hoc results from a randomised trial","volume":"108","author":"de Blay","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.anai.2015.03.022_bib49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaci.2010.09.017","article-title":"The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article","volume":"127","author":"Bousquet","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2015.03.022_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1939-4551-7-24","article-title":"Current status of sublingual immunotherapy in the United States","volume":"7","author":"Elenburg","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2015.03.022_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/ACI.0b013e328364580e","article-title":"Sublingual immunotherapy: the U.S. experience","volume":"13","author":"Nelson","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120615002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:12:15Z","timestamp":1761052335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120615002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1081120615002045"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2015.03.022","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual immunotherapy: focus on tablets","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2015.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}